Vincerx Pharma, Inc.
VINC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27,532 | $138,596 | $118,307 | $965,355 |
| - Cash | $4,987 | $12,782 | $11,663 | $111,459 |
| + Debt | $0 | $2,502 | $3,436 | $4,174 |
| Enterprise Value | $22,545 | $128,316 | $110,080 | $858,070 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$915 | -$939 | -$340 |
| % Margin | – | – | – | – |
| EBITDA | -$31,463 | -$39,242 | -$62,045 | -$38,966 |
| % Margin | – | – | – | – |
| Net Income | -$30,074 | -$40,157 | -$65,367 | -$39,306 |
| % Margin | – | – | – | – |
| EPS Diluted | -5.75 | -6.84 | -10.86 | -8.3 |
| % Growth | 15.9% | 37% | -30.8% | – |
| Operating Cash Flow | -$26,127 | -$40,453 | -$59,604 | -$33,402 |
| Capital Expenditures | $0 | $0 | $0 | -$5,258 |
| Free Cash Flow | -$26,127 | -$40,453 | -$59,604 | -$38,660 |